+211.3%
GDX vs THC
+413.3%
-202.0%
-38.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.2% | -1.1% | +3.3% | +2.3% |
| 7D | +13.6% | +3.7% | +9.9% | +13.0% |
| 30D | +2.5% | +9.0% | -6.5% | +1.2% |
| 3M | +4.4% | +10.4% | -6.0% | +2.8% |
| 6M | -5.2% | +45.7% | -50.9% | -10.7% |
| YTD | +2.1% | +42.6% | -40.4% | -3.9% |
| 1Y | +24.7% | +38.8% | -14.1% | +17.5% |
| 3Y | +211.3% | +418.8% | -207.5% | +125.2% |
| All | +211.3% | +413.3% | -202.0% | +125.2% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling